Surgeon profile
Sebastian F Schoppmann
Sebastian F Schoppmann is a general surgeon at Wiener Privatklinik (WPK) in Vienna, Austria.
Free Bookimed support. Compare options before deciding.
About the specialist and your treatment
Sebastian F Schoppmann is a general surgeon at Wiener Privatklinik (WPK) in Vienna, Austria. Sebastian F Schoppmann began medical practice in 2001. For stomach and esophagus care, inquiry topics include Esophagectomy and Gastroectomy. You can send an inquiry about Sebastian F Schoppmann through the Bookimed doctor page. The start year describes career experience, not a verified personal operation count or outcome record.
Sources (1)
Research topics
His research topics include the fibrinogen-albumin ratio in primarily resected gastroesophageal adenocarcinoma (2024). A 2021 publication concerns the Systemic Immune-Inflammation Index in gastroesophageal adenocarcinoma. A 2020 publication examines modification of preoperative radiochemotherapy for esophageal cancer using the CROSS protocol.
Sources (3)
- Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma.
- High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
- Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity.
Operations offered
| Specialist | Clinic | Operations and experience | Ask about treatment |
|---|---|---|---|
 Sebastian F Schoppmann | Wiener Privatklinik (WPK) Vienna, Austria | Esophagectomy; Gastroectomy In practice since 2001 | Ask about treatment |
Sources (1)
Research and sources
Sources (3)
- Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma.
- High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
- Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity.
Request a treatment proposal
Share your diagnosis and reports through the Bookimed request form.
Ask about treatment
Turn information into your next step.
Free Bookimed support. Compare options before deciding.
Free Bookimed support. Compare options before deciding.